KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Inventory Average (2016 - 2025)

Historic Inventory Average for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $11.6 billion.

  • Pfizer's Inventory Average fell 13.38% to $11.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $11.6 billion, marking a year-over-year decrease of 13.38%. This contributed to the annual value of $11.3 billion for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Pfizer's Inventory Average is $11.6 billion, which was down 13.38% from $11.3 billion recorded in Q2 2025.
  • Pfizer's Inventory Average's 5-year high stood at $11.6 billion during Q3 2024, with a 5-year trough of $8.3 billion in Q2 2021.
  • Its 5-year average for Inventory Average is $10.1 billion, with a median of $10.2 billion in 2023.
  • Its Inventory Average has fluctuated over the past 5 years, first skyrocketed by 1715.5% in 2022, then tumbled by 284.83% in 2023.
  • Quarter analysis of 5 years shows Pfizer's Inventory Average stood at $8.8 billion in 2021, then increased by 4.49% to $9.2 billion in 2022, then grew by 10.27% to $10.2 billion in 2023, then grew by 10.69% to $11.3 billion in 2024, then grew by 2.5% to $11.6 billion in 2025.
  • Its last three reported values are $11.6 billion in Q3 2025, $11.3 billion for Q2 2025, and $10.9 billion during Q1 2025.